Hematology/Oncology

Top Story

Yale School of Medicine appoints chair of surgery department

Yale School of Medicine appoints chair of surgery department
November 18, 2017

Nita Ahuja, MD, has been named chair of the department of surgery at Yale School of Medicine.

Ahuja also will serve as chief of surgery at Yale New Haven Hospital.

In the Journals Plus

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype

November 17, 2017
Radiotherapy prolonged OS among patients with all stages of nodular lymphocytic Hodgkin lymphoma, including those with B-symptoms, according to study results. However…
Meeting News

High compliance with Optune linked to greatest survival benefit for glioblastoma

November 17, 2017
Patients with newly diagnosed glioblastoma who used the Optune device more than 90% of the time had the greatest chance for survival, according to a company-issued press…

ASCO expands enrollment for TAPUR study

November 17, 2017
ASCO announced four cohorts of Targeted Agent and Profiling Utilization Registry, or TAPUR, will enroll additional patients with a variety of cancers. The combination of…
Meeting NewsVideo

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017
MIAMI Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal cell carcinoma at…
More Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Public’s reliance on Google costs physicians time with patients

November 1, 2017
More »
Resource Centers

CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Current Issues
View the Current Issue
HemOnc Today